Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NF-κB Signalling in Glioblastoma
Vincent Soubannier, Stefano Stifani
Biomedicines (2017) Vol. 5, Iss. 2, pp. 29-29
Open Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-κB Signaling Pathway
Fei‐Ting Hsu, I‐Tsang Chiang, Yu‐Cheng Kuo, et al.
The American Journal of Chinese Medicine (2019) Vol. 47, Iss. 04, pp. 913-931
Closed Access | Times Cited: 33
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways
Sarah Adriana Scuderi, Alessia Filippone, Rossella Basilotta, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13915-13915
Open Access | Times Cited: 17
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
Reshma Raghava Kurup, Eimile Oakes, Pranathi Vadlamani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Dysregulation of inflammasome activation in glioma
JeongMin Sim, JeongMan Park, Jong‐Seok Moon, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas
Abdou-samad Kone, Amina Ghouzlani, Ahmed Qandouci, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Harnessing the role of aberrant cell signaling pathways in glioblastoma multiforme: a prospect towards the targeted therapy
S. M. Murshid Hasan, Zimam Mahmud, Mahmud Hossain, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Targeting AGTR1/NF-κB/CXCR4 axis by miR-155 attenuates oncogenesis in glioblastoma
Anukriti Singh, Nidhi Srivastava, Anjali Yadav, et al.
Neoplasia (2020) Vol. 22, Iss. 10, pp. 497-510
Open Access | Times Cited: 27
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties
Alessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 25
The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
Mariana Medeiros, Marina Ferreira Cândido, Elvis Terci Valera, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 17-18, pp. 6161-6200
Closed Access | Times Cited: 21
Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines
Francesca Lombardi, Francesca Rosaria Augello, Serena Artone, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1545-1545
Open Access | Times Cited: 15
Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
Andra Krauze, Michael Sierk, Trinh Nguyen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Idiopathic male infertility and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking
Qiuqin Tang, Yiqiu Chen, Wei Wu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 26
Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis
Lindsey Lowder, Jennifer Hauenstein, Ashley Woods, et al.
Journal of Neuro-Oncology (2019) Vol. 143, Iss. 3, pp. 381-392
Open Access | Times Cited: 24
Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF‐κB/STAT3 Signaling
Markus Schweiger, Li Mao, Alberta Giovanazzi, et al.
Advanced Biosystems (2020) Vol. 4, Iss. 12
Open Access | Times Cited: 22
Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?
Ximena Vásquez, Pilar Sánchez‐Gómez, Verónica Palma
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8248-8248
Open Access | Times Cited: 19
Enhanced expression of pentraxin-3 in glioblastoma cells correlates with increased invasion and IL8-VEGF signaling axis
Umadevi V. Wesley, Ian Sutton, Paul A. Clark, et al.
Brain Research (2021) Vol. 1776, pp. 147752-147752
Closed Access | Times Cited: 19
The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
Lina Alhaddad, А. Н. Осипов, Sergey Leonov
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13577-13577
Open Access | Times Cited: 13
NFBTA: A Potent Cytotoxic Agent against Glioblastoma
Hasan Türkez, Flávio Rogério da Nóbrega, Özlem Özdemir Tozlu, et al.
Molecules (2019) Vol. 24, Iss. 13, pp. 2411-2411
Open Access | Times Cited: 20
The protection of NF‐κB inhibition on kidney injury of systemic lupus erythematosus mice may be correlated with lncRNA TUG1
Hai‐Yu Cao, Dong Li, Yun‐Peng Wang, et al.
The Kaohsiung Journal of Medical Sciences (2020) Vol. 36, Iss. 5, pp. 354-362
Open Access | Times Cited: 20
Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review
Ovais Shafi, Ghazia Siddiqui
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Targeting Key Signaling Pathways in Glioblastoma Stem Cells for the Development of Efficient Chemo- and Immunotherapy
Laureen P. Helweg, Jonathan J. Storm, Kaya E. Witte, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12919-12919
Open Access | Times Cited: 11
Immunomodulatory Role of Thioredoxin Interacting Protein in Cancer’s Impediments: Current Understanding and Therapeutic Implications
Ramkumar Katturajan, Sangeetha Nithiyanandam, Manisha Parthasarathy, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1902-1902
Open Access | Times Cited: 11
Embelin: A multifaceted anticancer agent with translational potential in targeting tumor progression and metastasis.
Adithya Jayaprakash Kamath, Alda Sara Chandy, Aina Ann Joseph, et al.
PubMed (2023) Vol. 22, pp. 1311-1329
Closed Access | Times Cited: 6
A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis
Ya-Ting Wen, Alexander T.H. Wu, Oluwaseun Adebayo Bamodu, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1442-1442
Open Access | Times Cited: 19
TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt
Hamed Hosseinalizadeh, Omid Mohamadzadeh, Mohammad Saeed Kahrizi, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 6

Scroll to top